David Fellows

David Fellows is the CEO of Beacon Therapeutics and the Chairman of Oxular. David also serves as the Board Chair at Terns Pharmaceuticals, a Board Member at Jaguar Gene Therapy and Gyroscope Therapeutics, and has previously held positions at Axovia Therapeutics and Arctos Optogenetics. Fellows is a former CEO of Nightstar Therapeutics and is a member of their Board of Directors. David attended Butler University from 1974 to 1978.